Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cazzolli, R.
Right arrow Articles by Schmitz-Peiffer, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cazzolli, R.
Right arrow Articles by Schmitz-Peiffer, C.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 50:2210-2218, 2001
© 2001 by the American Diabetes Association, Inc.

A Role for Protein Phosphatase 2A–Like Activity, but Not Atypical Protein Kinase C{zeta}, in the Inhibition of Protein Kinase B/Akt and Glycogen Synthesis by Palmitate

Rosanna Cazzolli, Lee Carpenter, Trevor J. Biden, and Carsten Schmitz-Peiffer

Garvan Institute of Medical Research, Sydney, Australia

We have shown previously that palmitate treatment of C2C12 skeletal muscle myotubes causes inhibition of the protein kinase B (PKB) pathway and hence reduces insulin-stimulated glycogen synthesis through the elevation of intracellular ceramide levels. Ceramide is known to activate both atypical protein kinase C (aPKC) {zeta} and protein phosphatase (PP) 2A, and each of these effectors has been reported to inhibit PKB. In the present study, palmitate pretreatment was found to elevate PP2A-like activity in myotubes and to prevent its inhibition by insulin. Incubation with the phosphatase inhibitor okadaic acid before insulin stimulation protected against the effect of the fatty acid on PKB phosphorylation. Palmitate was unable to inhibit PKB activity and glycogen synthesis in cells overexpressing the activated PKB mutant (T308D,S473D)-PKB{alpha}, which is unaffected by phosphatase. In contrast, PKB activity and glycogen synthesis were still inhibited by palmitate in cells overexpressing a membrane-targeted and, hence, activated PKB mutant that retains sensitivity to phosphatase. Although aPKC activity was also increased in palmitate-treated cells, overexpression of wild-type or kinase-dead aPKC{zeta} did not alter the inhibitory effects of the lipid on either stimulation of PKB or glycogen synthesis by insulin. We conclude that palmitate disrupts insulin signaling in C2C12 myotubes by promoting PP2A-like activity and, therefore, the dephosphorylation of PKB, which in turn reduces the stimulation of glycogen synthesis.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
C. Schmitz-Peiffer and T. J. Biden
Protein Kinase C Function in Muscle, Liver, and {beta}-Cells and Its Therapeutic Implications for Type 2 Diabetes
Diabetes, July 1, 2008; 57(7): 1774 - 1783.
[Full Text] [PDF]


Home page
DiabetesHome page
K. Hojlund, D. Glintborg, N. R. Andersen, J. B. Birk, J. T. Treebak, C. Frosig, H. Beck-Nielsen, and J. F.P. Wojtaszewski
Impaired Insulin-Stimulated Phosphorylation of Akt and AS160 in Skeletal Muscle of Women With Polycystic Ovary Syndrome Is Reversed by Pioglitazone Treatment
Diabetes, February 1, 2008; 57(2): 357 - 366.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. Alkhateeb, A. Chabowski, J. F. C. Glatz, J. F. P. Luiken, and A. Bonen
Two phases of palmitate-induced insulin resistance in skeletal muscle: impaired GLUT4 translocation is followed by a reduced GLUT4 intrinsic activity
Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E783 - E793.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
N. Ghosh, N. Patel, K. Jiang, J. E. Watson, J. Cheng, C. E. Chalfant, and D. R. Cooper
Ceramide-Activated Protein Phosphatase Involvement in Insulin Resistance via Akt, Serine/Arginine-Rich Protein 40, and Ribonucleic Acid Splicing in L6 Skeletal Muscle Cells
Endocrinology, March 1, 2007; 148(3): 1359 - 1366.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Suryawan, J. Escobar, J. W. Frank, H. V. Nguyen, and T. A. Davis
Developmental regulation of the activation of signaling components leading to translation initiation in skeletal muscle of neonatal pigs
Am J Physiol Endocrinol Metab, October 1, 2006; 291(4): E849 - E859.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. S. Lee, S. K. Pinnamaneni, S. J. Eo, I. H. Cho, J. H. Pyo, C. K. Kim, A. J. Sinclair, M. A. Febbraio, and M. J. Watt
Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites
J Appl Physiol, May 1, 2006; 100(5): 1467 - 1474.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. J. Watt, A. Hevener, G. I. Lancaster, and M. A. Febbraio
Ciliary Neurotrophic Factor Prevents Acute Lipid-Induced Insulin Resistance by Attenuating Ceramide Accumulation and Phosphorylation of c-Jun N-Terminal Kinase in Peripheral Tissues
Endocrinology, May 1, 2006; 147(5): 2077 - 2085.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Mounier, V. Dumas, and B. I. Posner
Regulation of Hepatic Insulin-Like Growth Factor-Binding Protein-1 Gene Expression by Insulin: Central Role for Mammalian Target of Rapamycin Independent of Forkhead Box O Proteins
Endocrinology, May 1, 2006; 147(5): 2383 - 2391.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Munteanu, M. Taddei, I. Tamburini, E. Bergamini, A. Azzi, and J.-M. Zingg
Antagonistic Effects of Oxidized Low Density Lipoprotein and {alpha}-Tocopherol on CD36 Scavenger Receptor Expression in Monocytes: INVOLVEMENT OF PROTEIN KINASE B AND PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-{gamma}
J. Biol. Chem., March 10, 2006; 281(10): 6489 - 6497.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. B. Haugaard, O. Andersen, S. Madsbad, C. Frosig, J. Iversen, J. O. Nielsen, and J. F.P. Wojtaszewski
Skeletal Muscle Insulin Signaling Defects Downstream of Phosphatidylinositol 3-Kinase at the Level of Akt Are Associated With Impaired Nonoxidative Glucose Disposal in HIV Lipodystrophy
Diabetes, December 1, 2005; 54(12): 3474 - 3483.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. V. Parry, J. M. Chemnitz, K. A. Frauwirth, A. R. Lanfranco, I. Braunstein, S. V. Kobayashi, P. S. Linsley, C. B. Thompson, and J. L. Riley
CTLA-4 and PD-1 Receptors Inhibit T-Cell Activation by Distinct Mechanisms
Mol. Cell. Biol., November 1, 2005; 25(21): 9543 - 9553.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. A. Summers and D. H. Nelson
A Role for Sphingolipids in Producing the Common Features of Type 2 Diabetes, Metabolic Syndrome X, and Cushing's Syndrome
Diabetes, March 1, 2005; 54(3): 591 - 602.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Rose, P. Froment, V. Perrot, M. J. Quon, D. LeRoith, and J. Dupont
The Luteinizing Hormone-releasing Hormone Inhibits the Anti-apoptotic Activity of Insulin-like Growth Factor-1 in Pituitary {alpha}T3 Cells by Protein Kinase C{alpha}-mediated Negative Regulation of Akt
J. Biol. Chem., December 10, 2004; 279(50): 52500 - 52516.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Perdomo, S. R. Commerford, A.-M. T. Richard, S. H. Adams, B. E. Corkey, R. M. O'Doherty, and N. F. Brown
Increased {beta}-Oxidation in Muscle Cells Enhances Insulin-stimulated Glucose Metabolism and Protects against Fatty Acid-induced Insulin Resistance Despite Intramyocellular Lipid Accumulation
J. Biol. Chem., June 25, 2004; 279(26): 27177 - 27186.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
P. Weyrich, K. Kapp, G. Niederfellner, M. Melzer, R. Lehmann, H.-U. Haring, and R. Lammers
Partitioning-Defective Protein 6 Regulates Insulin-Dependent Glycogen Synthesis via Atypical Protein Kinase C
Mol. Endocrinol., May 1, 2004; 18(5): 1287 - 1300.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. G. Burchfield, A. J. Lennard, S. Narasimhan, W. E. Hughes, V. C. Wasinger, G. L. Corthals, T. Okuda, H. Kondoh, T. J. Biden, and C. Schmitz-Peiffer
Akt Mediates Insulin-stimulated Phosphorylation of Ndrg2: EVIDENCE FOR CROSS-TALK WITH PROTEIN KINASE C {theta}
J. Biol. Chem., April 30, 2004; 279(18): 18623 - 18632.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
C. E. Chalfant, Z. Szulc, P. Roddy, A. Bielawska, and Y. A. Hannun
The structural requirements for ceramide activation of serine-threonine protein phosphatases
J. Lipid Res., March 1, 2004; 45(3): 496 - 506.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. M. Adams II, T. Pratipanawatr, R. Berria, E. Wang, R. A. DeFronzo, M. C. Sullards, and L. J. Mandarino
Ceramide Content Is Increased in Skeletal Muscle From Obese Insulin-Resistant Humans
Diabetes, January 1, 2004; 53(1): 25 - 31.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
D. J. Powell, E. Hajduch, G. Kular, and H. S. Hundal
Ceramide Disables 3-Phosphoinositide Binding to the Pleckstrin Homology Domain of Protein Kinase B (PKB)/Akt by a PKC{zeta}-Dependent Mechanism
Mol. Cell. Biol., November 1, 2003; 23(21): 7794 - 7808.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Tanaka, M. V. Gavrielides, Y. Mitsuuchi, T. Fujii, and M. G. Kazanietz
Protein Kinase C Promotes Apoptosis in LNCaP Prostate Cancer Cells through Activation of p38 MAPK and Inhibition of the Akt Survival Pathway
J. Biol. Chem., September 5, 2003; 278(36): 33753 - 33762.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Hardy, W. El-Assaad, E. Przybytkowski, E. Joly, M. Prentki, and Y. Langelier
Saturated Fatty Acid-induced Apoptosis in MDA-MB-231 Breast Cancer Cells: A ROLE FOR CARDIOLIPIN
J. Biol. Chem., August 22, 2003; 278(34): 31861 - 31870.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. A. Chavez, T. A. Knotts, L.-P. Wang, G. Li, R. T. Dobrowsky, G. L. Florant, and S. A. Summers
A Role for Ceramide, but Not Diacylglycerol, in the Antagonism of Insulin Signal Transduction by Saturated Fatty Acids
J. Biol. Chem., March 14, 2003; 278(12): 10297 - 10303.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. E. Wrede, L. M. Dickson, M. K. Lingohr, I. Briaud, and C. J. Rhodes
Protein Kinase B/Akt Prevents Fatty Acid-induced Apoptosis in Pancreatic beta -Cells (INS-1)
J. Biol. Chem., December 13, 2002; 277(51): 49676 - 49684.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C.-L. M. Soltys, L. Buchholz, M. Gandhi, A. S. Clanachan, K. Walsh, and J. R. B. Dyck
Phosphorylation of cardiac protein kinase B is regulated by palmitate
Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H1056 - H1064.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. Cazzolli, D. L. Craig, T. J. Biden, and C. Schmitz-Peiffer
Inhibition of glycogen synthesis by fatty acid in C2C12 muscle cells is independent of PKC-alpha , -epsilon , and -theta
Am J Physiol Endocrinol Metab, June 1, 2002; 282(6): E1204 - E1213.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2001 by the American Diabetes Association.